About the Journal
- ISSN Number (print) 1450-1147
General Information
This is the official journal of the World Federation
of Nuclear Medicine & Biology (WFNMB) with
the support of the IAEA and is published quarterly.
The purposes of the journal are as follows:
-
To be an official publication of the World
Federation of Nuclear Medicine & Biology
(WFNMB) with the active collaboration and
support of the IAEA
-
To promote research in nuclear medicine
globally and in the developing countries
in particular
-
To promote good practice in nuclear medicine
Target Group:
- All
members of the WFNMB
- All member states
of IAEA
- Specialists belonging
to various fields of nuclear medicine (Physicians,
radiopharmacists, physicists, radioimmunoassayists,
molecular biologists, etc.), technologists
and nurses
- Manufacturers of
equipment and reagents relevant to nuclear
medicine
- Atomic Energy Commissions,
Governmental and administrative personnel
relevant to nuclear medicine practice in
the various countries
Contents
a. General:
Reviews related
to the good practice of nuclear medicine.
b. Related to
WFNMB:
Newsletter
Announcements
Reports of working groups, etc.
Editorials on WFNMB Planning & Strategy
etc.
Abstracts of Congresses
c. Related to
IAEA and other International organizations:
Newsletter
Announcements
Reports of CRPs, RCMs, Seminars
Abstracts of International Seminars
Periodic world status reports
Regional Windows, Editorials
Cochrane Reviews
d. Research
& Development:
CMEs on Clinical
subjects as well as on Science & Technology
pertaining to nuclear medicine
Original articles.
Letters to the editor
e. Windows for
the Industry
(coloured pages)
Display
Commercial Advertising
It is hoped that
the nuclear medicine industry (radiopharmaceuticals,
nuclear instrumentation, computer & reagents
etc.) will view the journal as an effective
means of advertising to the nuclear medicine
community. In order that the journal can be
self-sustaining, we invite the industry to provide
significant support and to assist in raising
the profile of this important journal, the first
to specifically target the world-wide nuclear
medicine community. Besides regular full, half
and quarter page advertisements, the journal
will also publish special features like "windows
for the industry". All advertising materials
accepted are expected to conform to ethical,
medical and business standards. Acceptance does
not imply endorsement by the journal.
|
